Literature DB >> 17645980

Assessing genetic testing: who are the "lay experts"?

Joanna Goven1.   

Abstract

This paper addresses the question of expertise in relation to technology assessments, arguing both that "lay expertise" is necessary and that "lay expertise" should not be interpreted as equivalent to "patient expertise". It presents findings from a prospective study of the social implications of genetic testing for susceptibility to occupational disease and injury. The findings support the view that technologies cannot be adequately assessed in isolation from the socio-political context in which they will be utilised. Interviews with those possessing non-traditional, "lay" expertise in seeking compensation for occupational disease and/or long-term disability identified a range of institutional practices which, unless they are addressed, will significantly increase the dangers of utilizing genetic testing. The paper concludes that adequate assessment of a technology can be impeded by a focus on the technology itself, particularly when the impact of a technology may be to exacerbate already problematic aspects of existing social and political institutions.

Entities:  

Mesh:

Year:  2007        PMID: 17645980     DOI: 10.1016/j.healthpol.2007.06.004

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  3 in total

1.  The integration of citizens into a science/policy network in genetics: governance arrangements and asymmetry in expertise.

Authors:  Geneviève Daudelin; Pascale Lehoux; Julia Abelson; Jean L Denis
Journal:  Health Expect       Date:  2010-10-28       Impact factor: 3.377

2.  Involving patients in HTA activities at local level: a study protocol based on the collaboration between researchers and knowledge users.

Authors:  Marie-Pierre Gagnon; Johanne Gagnon; Michèle St-Pierre; François-Pierre Gauvin; Florence Piron; Marc Rhainds; Martin Coulombe; Dolores Lepage-Savary; Marie Desmartis; Mylène Tantchou Dipankui; France Légaré
Journal:  BMC Health Serv Res       Date:  2012-01-16       Impact factor: 2.655

3.  An effective multisource informed consent procedure for research and clinical practice: an observational study of patient understanding and awareness of their roles as research stakeholders in a cancer biobank.

Authors:  Silvia Cervo; Jane Rovina; Renato Talamini; Tiziana Perin; Vincenzo Canzonieri; Paolo De Paoli; Agostino Steffan
Journal:  BMC Med Ethics       Date:  2013-07-30       Impact factor: 2.652

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.